Cardiac Magnetic Resonance Left Atrioventricular Coupling Index as a Prognostic Tool in Hypertrophic Cardiomyopathy
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15237 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Jinyang Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Magnetic Resonance Imaging, Cine, Heart Atria, Heart Ventricles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance-derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still not been studied thoroughly, so we aimed to explore the association between LACI and adverse clinical outcomes in HCM patients.
Methods
A total of 206 HCM patients underwent cardiac magnetic resonance examination were retrospectively enrolled. LACI is defined by the ratio between the left atrial (LA) volume and the left ventricular (LV) volume in LV end-diastolic phase. The composite endpoint was categorized into death-related, heart failure-related, and arrhythmia-related events, reflecting mortality risk, heart failure progression, and arrhythmia burden, respectively. Receiver operating characteristics curve analysis was used to determine the optimal cut-off value for LACI to distinguish HCM patients at high risk of adverse clinical outcome. Multivariable Cox regression models were built including significant clinical variables, LA ejection fraction (LAEF), LA volume index (LAVI), late gadolinium enhancement (LGE) extent and LACI. The improvement of discrimination by adding LACI to a clinical model was assessed using C-statistic, net reclassification improvement (NRI) and integrated discrimination improvement (IDI).
Results
Thirty-four HCM patients reached the endpoint during a median follow-up time of 60 [interquartile range (50–68)] months. In the multivariate Cox regression analysis, LACI [hazard ratio 1.054, 95% confidence interval (CI): 1.037, 1.071; P < 0.001] was an independent predictor of the composite events after adjustment for age and atrial fibrillation. Then 40.09% was identified as an optimal cut-off for LACI in the risk stratification. Integrating LACI to the clinical model yielded higher C-statistic 0.892 with 95% CI (0.861, 0.922) compared with LA diameter, LAEF, LAVI and LGE extent, providing an improvement in prediction of high-risk patients (NRI = 0.627, 95% CI: 0.112–0.934; IDI = 0.295, 95% CI: 0.016–0.709).
Conclusions
LACI is an independent risk factor for clinical adverse outcome and is superior to conventional LA parameters and LGE extent for the identification of high-risk HCM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Bayer Healthcare, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wen, J., Tu, J., Tao, X., Tang, Y., Yang, Z., Pan, Z., Luo, Y., Xiang, C., Tang, D., Huang, L., & Xia, L. (2025). Cardiac Magnetic Resonance Left Atrioventricular Coupling Index as a Prognostic Tool in Hypertrophic Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.15237
Vancouver
Wen J, Tu J, Tao X, Tang Y, Yang Z, Pan Z, et al. Cardiac Magnetic Resonance Left Atrioventricular Coupling Index as a Prognostic Tool in Hypertrophic Cardiomyopathy. ESC Heart Failure. 2025. doi:10.1002/ehf2.15237
BibTeX
@article{Wen2025,
author = {Wen, Jinyang and Tu, Junhao and Tao, Xinwei and Tang, Yuanyuan and Yang, Zhaoxia and Pan, Ziyi and Luo, Yi and Xiang, Chunlin and Tang, Dazhong and Huang, Lu and Xia, Liming},
title = {Cardiac Magnetic Resonance Left Atrioventricular Coupling Index as a Prognostic Tool in Hypertrophic Cardiomyopathy},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15237}
}
EUVIMED